Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

NORML

MARCH 1, 2019

In Congress this week Senator Cory Booker (D-NJ), along with Representatives Barbara Lee (D-CA) and Ro Khanna (D-CA), introduced The Marijuana Justice Act of 2019, to remove marijuana from the Controlled Substances Act and incentivize states to end the racially disparate criminalization of marijuana consumers. Actions to Take. AR resident?

Legislation 167

Legislation Compliance Compliance Hemp 167

Cannabis Law Report

JUNE 24, 2021

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Complementary therapy.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

NORML

JANUARY 11, 2019

HR 420 (yes, you read that right): The Regulate Marijuana Like Alcohol Act would deschedule cannabis from the Controlled Substances Act, thus permitting state governments to regulate these activities as they see fit. Also, the rollout of the new leadership team of the Congressional Cannabis Caucus was announced. Your Highness, Carly.

Legislation 190

Legislation Decriminalization Hemp Patients 190

Cannabis Law Report

AUGUST 19, 2021

Cantourage, one of Europe’s leading providers of medical cannabis, has today launched its offering of high-quality medical cannabis flowers from Jamaica in Germany. Cantourage has successfully partnered with Australian-based Cannim, the leading cultivator of medicinal cannabis in Jamaica.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JUNE 7, 2021

The Phase 1 clinical trial on Alzheimer’s patients is currently anticipated to conclude during the July through September 2021 timeframe. IGC) engages in the development of cannabinoid-based therapies for indications such as Alzheimer’s disease, Parkinson’s disease, and pain. About IGC: India Globalization Capital, Inc.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

AUGUST 3, 2022

As our firm’s prior information memos on cannabis have shown 1 , the legalization of marijuana for recreational or medical use in states still poses legal issues in higher education due to marijuana’s illegality under federal law. This tension in laws is also present in the issue of marijuana use by patients in hospital settings.

Research and Development 98

Research and Development Policy Patients Compliance 98

The Cannigma

JUNE 1, 2021

While France has long been said to have the highest number of cannabis users per capita in Europe, it has long lagged behind its western Europe neighbors when it comes to tolerance of the plant. Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Shutterstock.

Law 113

Law Epilepsy Programs Patients 113

NORML

FEBRUARY 22, 2019

Regulators in Iowa added two new medical cannabis qualifying conditions to the current list, ulcerative colitis (effective immediately), and severe pediatric autism with self-injurious or aggressive behaviors (effective 4/2/19). Click here to email your lawmakers in support of allowing patients to smoke medical cannabis.

Legislation 175

Legislation Hemp Compliance Compliance 175

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. By Rachael Maddison with Bradley Slaughter • 24 Apr, 2019. An intro to terpenes and how they work in hemp and cannabis. We, here at StrainConnect, are your go-to resource for all things hemp CBD and cannabis. Leading cannabis terpene researcher, Dr. Jeffrey C.

Terpenes 63

Terpenes Cannabinoids Therapy Hybrid 63

Veriheal

JUNE 19, 2023

In a study done in 2018 , when LSD was used alongside psychotherapy, patients experienced greater feelings of empathy, trust, and happiness. Food & Drug Administration in 2019 when it was found to work for patients who were unresponsive to other treatments. It was approved by the U.S.

Therapy 109

Therapy Treatment Patients Policy 109

Veriheal

JANUARY 15, 2021

. “Next year, People Before Profit will bring forward legislation to end the prohibition of cannabis in Ireland. This will be the first time in eight years that a bill to legalize cannabis will be before the Dáil. Next year People Before Profit will bring forward legislation to end the prohibition of cannabis in Ireland.

Legalization 57

Legalization Therapy Access Legislation 57

Canna Law Blog

FEBRUARY 24, 2020

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. 30 Day Public Comment period ended on 4th December 2019.

Decriminalization 130

Decriminalization Therapy Research and Development Treatment 130

Cannabis Law Report

JANUARY 20, 2022

The company said IV-administered psilocin has the potential to “offer more consistent therapeutic effects to patients, more controllable therapies to clinicians, and shorter treatment times than orally-administered psilocybin exhibited in third-party clinical studies.”. Food and Drug Administration in 2019.

Research and Development 52

Research and Development Therapy Access Patients 52

NORML

JANUARY 18, 2019

Representative Lou Correa (D-CA) this week introduced HR 493: The Sensible Enforcement Of Cannabis Act, which would codify the protections that were outlined in the now-rescinded Cole Memo. House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis.

Legislation 158

Legislation Decriminalization Access Therapy 158

Cannabis Law Report

JULY 16, 2021

Cannabis Thereputica reported 14 July 2021 (Google Translate). The basic text on home cannabis cultivation will be presented today in the Justice Commission . Without forgetting the patients who, as has been the case for years, are without therapy given the cannabis shortage that cyclically leaves patients without their drug.

Cultivation 105

Cultivation Therapy Patients Cannabis 105

Cannabis Law Report

JULY 9, 2021

The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.

Law 105

Law Therapy Clinical Trials Research and Development 105

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 236

Legislation Patients Decriminalization Access 236

TheAnswerPage

OCTOBER 22, 2021

How should a clinician monitor the outcome of cannabinoid-based therapy? As suggested by the Australian Centre for Cannabinoid Clinical and Research Excellence, monitoring should initially involve reviewing the patient weekly in person, and via phone if required in the interim between clinical reviews. “ Drug adverse events.

Therapy 59

Therapy Events Cannabinoids Concentrates 59

MassRoots

AUGUST 3, 2020

Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 819.

Programs 124

Programs Banking Marijuana Conditions 124

Veriheal

AUGUST 28, 2023

This unanimous decision by the Board updates Ohio ‘s qualifying conditions, now placing IBS as number twenty-six (26) on the list of ailments for which residents of the state can medically access cannabis for therapeutic purposes. While some IBS patients struggle with diarrhea, others only have to contend with constipation.

Conditions 52

Conditions Treatment Digestion Patients 52

NORML

MARCH 8, 2019

Activists in Nebraska, along with two pro-legalization Senators, qualified a 2020 medical cannabis ballot initiative petition to begin collecting signatures from registered voters in the state. Legislation is pending, Senate Bill 440, to prohibit the availability of cannabis-infused food and drink products for qualified patients.

Legislation 165

Legislation Patients Access Seed-To-Sale 165

Cannabis Law Report

NOVEMBER 3, 2021

Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF )(Frankfurt:A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , is pleased to announce the opening of Zerenia™ Clinics UK in London as its first International Zerenia™ clinic in Europe. Khiron Life Sciences Corp.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

JULY 16, 2021

The 14-member board is now fully staffed and ready to oversee the state’s forthcoming medical cannabis program. The Alabama Medical Cannabis Commission received its final appointments this week, and the 14-member board is now fully staffed and ready to oversee the state’s forthcoming medical cannabis program. Source: [link].

Chronic Pain 105

Chronic Pain Epilepsy Programs Therapy 105

NORML

FEBRUARY 1, 2019

Governor of Pennsylvania, is beginning a state-wide listening tour to find out where PA residents stand on cannabis legalization. Manor Township, Pennsylvania is considering a proposal that would decriminalize cannabis possession. The measure would permit medical cannabis patients to grow up to six cannabis plants.

Legislation 160

Legislation Decriminalization Access Patients 160

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

NORML

MARCH 7, 2020

Legislation is pending, HCR 2045, that seeks to arbitrarily cap the potency of cannabis flowers at two percent THC. Legislation is pending, House Bill 2049, that would expand the pool of individuals eligible for medical cannabis. Legislation is pending, Senate Bill 2787, to regulate medical cannabis delivery services.

Legislation 228

Legislation Decriminalization Patients THC 228

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

The Cannigma

SEPTEMBER 21, 2021

of respondents stated that they use CBD alongside Applied Behavior Analysis Therapy, which they write runs counter to the recommendations of many healthcare professionals that CBD not be used on its own to treat autism symptoms. Cannabis has shown the potential to be effective in treating symptoms of Autism Spectrum Disorder (ASD).

CBD 143

CBD Treatment Environment Sleep 143

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. .

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

NORML

NOVEMBER 8, 2019

Yet, even in the majority of states where medical cannabis is legal, VA physicians are prohibited by federal law from filling out a state-legal medical marijuana recommendation form. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 204

Access Marijuana Treatment Legislation 204

Cannabis Law Report

JANUARY 23, 2022

I was a young cannabis research student on my first trip overseas to an international research conference. GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. and 13.4%, respectively. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

FEBRUARY 28, 2022

Moreover, because Indigenous communities pioneered many aspects of modern psychedelic therapies, their patenting by Western corporations may promote biopiracy, the exploitation of Indigenous knowledge without compensation. Simon Makin, Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain , SCI. 10 × 10.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

FEBRUARY 3, 2022

Just a few years ago, Oklahoma would have been one of the last places you’d want to get caught in possession of cannabis. In 2018 Oklahoma voters headed to the ballot and approved medical cannabis legalization. Oklahoma Medical Cannabis Program Prospers. Oklahoma Medical Cannabis Program’s Problems.

Programs 52

Programs Seed-To-Sale Wellness and Beauty Compliance 52

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] More recently, MDMA therapy has inched closer to FDA approval. and Seattle, among other municipalities. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

NORML

MARCH 22, 2019

Activists in Oregon have filed a 2020 ballot initiative with the Secretary of State that, if approved, would allow social cannabis consumption sites and protect consumers from employment discrimination. Governor Ron DeSantis (R) of Florida signed legislation into law to restore patients’ right to smoke medical cannabis.

Legislation 132

Legislation Hemp Patients Compliance 132

NORML

MARCH 14, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 183

Legislation Access Patients THC 183